NPPA Caps Prices of 39 New Medicines. Check the Full Drug List
- The National Pharmaceutical Pricing Authority fixed retail prices for 39 new drug formulations under the Drugs Order, 2013, covering treatments for hypertension, diabetes, HIV, heart disease, and eye infections to improve affordability.
- The NPPA set specific maximum retail prices including Amlodipine + Bisoprolol + Telmisartan tablets at Rs 14.74 per tablet, Nepafenac + Moxifloxacin ophthalmic solution at Rs 68.64 per ml, and Clopidogrel + Aspirin + Atorvastatin capsules at Rs 6.37 per capsule.
- Manufacturers charging above the notified prices must deposit the excess amount with interest, and retailers are required to prominently display price lists as per the provisions of the DPCO to ensure compliance.
- The pricing regulation includes essential medicines aiming to improve affordability and access across India.
12 Articles
12 Articles
Govt fixes retail prices of 39 medicines: Full list and what happens if you're overcharged
A notice by the Ministry of Chemicals and Fertilizers issued on July 8 stated the National Pharmaceutical Pricing Authority fixed the retail price of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.
NPPA Caps Retail Prices of 39 Medicines, Price Hike for Anti-rabies Immunoglobulin Injection
Get latest articles and stories on Business at LatestLY. The National Pharmaceutical Pricing Authority (NPPA) has notified revised retail prices for essential medicines, including a price fixation for Calcium and Vitamin D3 Tablets and a revision for Anti-Rabies Immunoglobulin injection. The regulator has also capped retail prices of 39 commonly used medicines used for hypertension, diabetes, heart disease and other therapies. Business News | NP…
Government Fixes Ceiling Prices for 39 Key Medicines Used for Diabetes, BP and Heart Ailments
In a move aimed at making treatment more affordable, the Central Government has brought 39 widely used medicines for diabetes, hypertension, heart ailments and other chronic diseases under price control, offering relief to millions of patients across the country. The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for these medicines under the provisions of the Drugs (Prices Control) Order, 2013, preventing manufacturers…
Coverage Details
Bias Distribution
- 75% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
